Successful multidisciplinary treatment of uterine serous carcinoma in a patient who had previously undergone renal transplantation.

Taiwan J Obstet Gynecol

Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taiwan. Electronic address:

Published: August 2018

Objective: Renal transplantation is a risk factor for premalignant and malignant changes of the endometrium. Thus, prompt and aggressive treatment of postoperative complications remains a major issue. We report the case of an asymptomatic postmenopausal woman with a history of renal transplantation who underwent surgery for uterine serous carcinoma (USC).

Case Report: An asymptomatic 59-year-old woman who had undergone renal transplantation presented with elevated serum CA-125 levels. Cancer screening revealed uterine serous carcinoma, for which she underwent total hysterectomy and bilateral salpingo-oophorectomy. Unfortunately, the postoperative course was complicated by cardiogenic shock and decompensated heart failure. The complexities of the cardiac problems and renal transplantation required a multidisciplinary approach involving different specialists. She was successfully discharged 48 days after the surgery.

Conclusion: Gynecologic cancer screening in asymptomatic postmenopausal women after renal transplantation is warranted. If postoperative complications occur in this population, a multidisciplinary approach is recommended.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tjog.2018.06.023DOI Listing

Publication Analysis

Top Keywords

renal transplantation
24
uterine serous
12
serous carcinoma
12
undergone renal
8
postoperative complications
8
asymptomatic postmenopausal
8
cancer screening
8
multidisciplinary approach
8
renal
6
transplantation
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!